About Biotie Therapies
Biotie is a drug development company focusing on dependence disorders, inflammatory diseases and thrombosis. The most advanced drugs in development are nalmefene for alcoholism (phase III) and impulse control disorders (phase II), monoclonal VAP-1 antibody and small molecule VAP-1 SSAO enzyme inhibitor for inflammatory diseases (late preclinical), and recombinant bioheparin for thrombosis (preclinical). The company is also developing a small molecule a2b1-integrin inhibitor for thrombosis and cancer, and has extensive immaterial property rights and know-how on its K5 polysaccharide technology platform to develop carbohydrate based pharmaceuticals.
Facts about Biotie Therapies
Facts about Biotie Therapies
- Focus : Manufacturer
- Industry : Pharma
